Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elaina Pirruccello

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
American Journal of Clinical Pathology|June 23, 2021
LILRB1: A Novel Diagnostic B-Cell Marker to Distinguish Neoplastic B Lymphoblasts From HematogonesSilvia Saumell Tutusaus, Elaina Pirruccello, Franklin Fuda, et al.
Cytometry. Part B, Clinical Cytometry|February 9, 2019
Bright CD38 Expression by Flow Cytometric Analysis Is a Biomarker for Double/Triple Hit Lymphomas with a Moderate Sensitivity and High SpecificityAbdullah Alsuwaidan, Elaina Pirruccello, Jesse Jaso, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
American Journal of Clinical Pathology|June 23, 2021
LILRB1: A Novel Diagnostic B-Cell Marker to Distinguish Neoplastic B Lymphoblasts From HematogonesSilvia Saumell Tutusaus, Elaina Pirruccello, Franklin Fuda, et al.
Cytometry. Part B, Clinical Cytometry|February 9, 2019
Bright CD38 Expression by Flow Cytometric Analysis Is a Biomarker for Double/Triple Hit Lymphomas with a Moderate Sensitivity and High SpecificityAbdullah Alsuwaidan, Elaina Pirruccello, Jesse Jaso, et al.
Pageof 1